Lianbio (LIAN) - News Archive

In a recent announcement, LianBio, a prominent biotechnology company focused on delivering groundbreaking medicines to patients in China and other Asian markets, revealed its decision to voluntarily delist its American...

In a recent press release, data management platform Komprise announced that it has experienced a significant boost in business, with a doubling of subscriptions in 2023. This growth can be attributed to both the increas...

In an official press release yesterday, LianBio, a leading biotechnology company, announced its decision to commence the wind-down of its operations. The strategic move involves the sale of remaining assets, reduction i...

In a significant development for the biotechnology sector, LianBio, a leading player focused on accelerating the differentiation and development of innovative medicines in China and other major Asian markets, has announ...

LianBio Announces Resignation of CEO Yizhe Wang, Ph.D., Amidst Steady Growth in the Biotechnology Industry SHANGHAI, China, and PRINCETON, N.J., Dec. 19, 2023 - LianBio (Nasdaq: LIAN), a leading biotechnology company co...

LianBio Rejects Acquisition Proposal from Concentra Biosciences, Focusing on Innovative Medicines for Asian MarketsShanghai, China and Princeton, N.J. - LianBio (NASDAQ: LIAN), a leading biotechnology company committed...

In a recent development, LianBio, a leading biotechnology company specializing in innovative medications for the Chinese and Asian markets, confirmed today that it has received an unsolicited proposal from Concentra Bio...